Lifeward Ltd. announced its financial results for the second quarter of 2025 on August 14, 2025, reporting revenue of $5.7 million. This represents a 15% decrease from $6.7 million in Q2 2024, but a 14% increase from Q1 2025.
The company's GAAP operating expenses increased to $9.1 million, largely due to a $2.8 million goodwill impairment charge triggered by a decline in share price. On a non-GAAP adjusted basis, operating expenses decreased by $0.9 million to $6.0 million, reflecting efficiency measures and lower R&D spending.
Lifeward reported a GAAP net loss of $6.6 million, or $0.58 per share. As of June 30, 2025, cash and cash equivalents stood at $5.1 million, with cash used in operations improving to $3.9 million. The company reset its full-year 2025 revenue guidance to $24 million to $26 million and non-GAAP net loss to $12 million to $14 million.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.